the retail buyer and the consumer/shopper. This objective picture of the two viewpoints should contribute to a product’s success at retail. In this column, we explore the ways promotion impacts buyer and shopper behavior.
The passage of the Patient Protection and Affordable Care Act in 2010 (ACA) promised fundamental changes in the American health care environment.
Can retail pharmacies beat other players to patient intimacy? Many pharmacy retailers understand that big data can improve business operations, enabling intimate consumer engagement and thereby driving bigger baskets and more door turns, along with healthier customers and margins.
As the Christmas selling season begins, it’s becoming increasingly apparent that mass retailers are concerned about business. Not that they have nothing to offer their customers; rather, they have little to offer that’s exciting, new, different, compelling, or even mildly interesting.
The Republican wave that swept across the country in this month’s midterm elections transformed the political landscape and raised hopes, however fragile, that the gridlock that has come to characterize Washington in recent years might be alleviated, if not completely overcome.
Mass market retailing, once the scene of an apparently ongoing string of meetings, conferences, exhibit shows and discussions, has morphed into an industry where such gatherings are disappointingly few and far between.
A New Prescription for Health Care Improvement” examines a previously murky aspect of the problem: newly prescribed drugs
exactly. Rather, the issue is that retailing, just prior to the Christmas selling season, has become dangerously internalized — and socialized. The talk these days is all about individual companies and the issues that surround them. Perhaps more ominous, much of the discussion revolves around social
Gilead Sciences and its breakthrough work in developing treatments for hepatitis C, the frequently devastating liver disease, have in recent months become the focal point of the debate about the cost and benefits of pharmaceutical products.
The Wild West never lacked for traveling salesmen pushing the newest elixir or snake oil to solve all your medical maladies.
In a multipart series throughout 2014, our team is examining key product attributes and marketing tactics from two different perspectives: the retail buyer and the consumer/shopper. This objective picture of the two viewpoints should contribute to a product’s success at retail.
Recently, Walmart announced it would open a dozen Walmart Care Clinics, primary care medical facilities, in stores in under-served communities.
The three most influential health care retailers in America are drug chains. They are, in no particular order, Walgreens, CVS Health and Rite Aid. In a sense, this is a surprise. Over the past several years, every major mass retailer in the U.S. has put an emphasis on health care.
The nation’s health care system is in upheaval, with, to borrow a phrase from William Wordsworth, “the meagre, stale, forbidding ways of custom” under siege.
In a year crammed with major news stories, cataclysmic personnel shifts and stunning new strategies and directions, the No. 1 retailing story of 2014 increasingly appears to be the CVS decision, announced early this year, to stop selling tobacco products in its 7,700 drug stores.
October 1 is the first anniversary of the debut of the federal and state health care exchanges that allow Americans to assess insurance options and purchase coverage under the Affordable Care Act. Since then 7.3 million people have signed up, and another 4.
